MDxHealth’s ConfirmMDx™ for Prostate Cancer Test Helps to Identify Men Able to Avoid Repeat Biopsies – StreetInsider.com

IRVINE, Calif. & LIEGE, Belgium–(BUSINESS WIRE)– Regulatory News: MDxHealth SA (NYSE Euronext: MDXH), a leading molecular diagnostic company that develops and commercializes epigenetic tests to support cancer treatment, today announced it has presented …

Posted in Uncategorized